Last edition
News about
FDA Continues to Accelerate Development of Novel Therapies for COVID-19
As part of the Trump Administration's all-hands-on-deck approach across public, academic and private sectors to combat the COVID-19 pandemic, the U.S. Food and Drug Administration stood up a new program to expedite the development of potentially safe and effective life-saving treatments
The COVID-19 pandemic is straining health systems worldwide. The rapidly increasing demand on health facilities and health care workers threatens to leave some health systems overstretched and unable to operate effectively
With more than 7 lakh people across the globe infected and nearly 38,000 people killed due to the highly infectious and deadly coronavirus, the Hyderabad-based researchers from University of Hyderabad (UoH) have come out with a potential solution that could lead to the development of a vaccine at a faster pace than anticipated by the scientists
Bayer to boost Germany's COVID-19 analysis capacity by several thousand tests per day
Bayer is undertaking further measures to support the fight against the coronavirus pandemic. At various sites in Germany, the company is making available more than 40 virus diagnostics devices from its research operations, enabling Germany's COVID-19 analysis capacity to be increased by several thousand tests daily
FDA expedites review of diagnostic tests to combat COVID-19
The U.S. Food and Drug Administration has been providing unprecedented flexibility to labs and manufacturers to develop and offer COVID-19 tests across the U.S. The FDA's regulations have not hindered or been a roadblock to the rollout of tests during this pandemic
Five pharma employees among seven new COVID-19 positive cases in Karnataka
Five employees of a pharmaceutical company based in Nanjangud were among seven new COVID-19 positive cases reported in Karnataka in the last 48 hours. The five pharma employees were colleagues of P52, a 35-year-old male and resident of Mysuru working in quality assurance department of a well known national pharma company
The first patient outside of the U.S. has been treated as part of a global clinical program evaluating Kevzara in patients hospitalized with severe COVID-19. The global clinical program has now been initiated in Italy, Spain, Germany, France, Canada, Russia and the United States, all countries that have been impacted by COVID-19
Abbott announced that the US Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes
Sun Pharmaceutical Industries Ltd. today announced its commitment to donate INR 250 Million (Indian Rupees Two Hundred and Fifty Million) of Hydroxychloroquine (HCQS), Azithromycin, other related drugs and hand sanitizers to support India's COVID-19 pandemic response
Corornavirus lockdown: Govt Orders Smooth Movement of Medial Equipments, Medicines
The central government has issued urgent orders to ensure smooth movement of medicines and other medical equipment in hospitals across the country which remains under a lockdown to contain the spread of novel coronavirus infection
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy